8-K: FOXO Technologies Subsidiary Secures Second Year of Opioid Abatement Funding Amidst Capacity Operations

Sentiment:

Operational Update


FOXO Technologies Inc.'s behavioral health subsidiary, Myrtle Recovery Centers, Inc., has been approved to receive Scott County Opioid Abatement Funds for a second consecutive year, starting July 1, 2025, to provide care for uninsured patients.

Better than expectedMyrtle Recovery Centers, Inc. received approval for a second year of Scott County Opioid Abatement Funds, indicating sustained support and success.The facility is operating at capacity and has a waiting list of patients, demonstrating high demand for its services and efficient utilization of resources.

Summary

  • Myrtle Recovery Centers, Inc., a behavioral health subsidiary of FOXO Technologies Inc., has secured approval for a second year of Scott County Opioid Abatement Funds.
  • The funding, effective July 1, 2025, will support care for uninsured patients from Scott County at Myrtle's Oneida, Tennessee location.
  • Myrtle's facility is currently operating at full capacity and maintains a waiting list for patients, indicating high demand for its services.
  • FOXO Technologies Inc. operates three subsidiaries: Rennova Community Health, Inc. (Scott County Community Hospital), Myrtle Recovery Centers, Inc. (30-bed behavioral health facility), and FOXO Labs, Inc. (biotechnology).

Sentiment

Score: 8

Explanation: The sentiment is highly positive due to the renewal of critical funding for a second year, the subsidiary operating at full capacity with a waiting list, and management's strong outlook on future revenue and expansion. The only minor detractions are the lack of specific financial figures for the grant and the general risk disclosure about past losses.

Positives

  • Myrtle Recovery Centers received funding for a second consecutive year, demonstrating continued support and recognition for its services.
  • The facility is operating at capacity with a waiting list, indicating strong demand and effective service delivery.
  • The funding enables the provision of critical behavioral health care to uninsured patients from Scott County.
  • Management anticipates that Myrtle will contribute significant revenue and value to FOXO Technologies in future years.
  • FOXO plans to expand Myrtle's footprint through both organic growth and strategic acquisitions.

Negatives

  • The document does not specify the monetary value of the Scott County Opioid Abatement Funds.
  • FOXO Technologies has a history of losses and may not achieve or maintain profitability in the future, as noted in the forward-looking statements.

Risks

  • Changes in the competitive and highly regulated industries in which FOXO operates.
  • Variations in operating performance across competitors or changes in laws and regulations affecting FOXO's business.
  • The ability to implement FOXO's business plans, forecasts, and other expectations.
  • The ability to obtain necessary financing.
  • The risk that FOXO has a history of losses and may not achieve or maintain profitability in the future.
  • Potential inability of FOXO to establish or maintain relationships required to advance its goals or to achieve its commercialization and development plans.
  • The enforceability of FOXO's intellectual property, including its patents, and the potential infringement on the intellectual property rights of others.
  • The risk of downturns and a changing regulatory landscape in the highly competitive biotechnology industry or in the markets or industries in which FOXO operates.

Future Outlook

FOXO Technologies anticipates expanding Myrtle Recovery Centers into additional locations through organic growth and acquisition, expecting the subsidiary to contribute significant revenue and value in future years. The company also looks forward to demonstrating continued successes in the second quarter of 2025, to be detailed in its upcoming quarterly report.

Management Comments

  • Robert Merritt, CEO of Myrtle Recovery Centers, Inc., stated: "We appreciate the support from Scott County to provide care for uninsured patients from the community that might otherwise not receive the care they need. To receive this support for a second year running combined with our facility operating at capacity and with a waiting list of patients is an acclamation for the quality of care our clinical team provides. We look forward to further expanding our footprint and offering our proven clinical program to an expanded patient base."
  • Seamus Lagan, CEO of FOXO Technologies Inc., added: "We are pleased at how Myrtle has ramped up operations and made a significant impact in the rural communities it serves. We look forward to expanding Myrtle into additional locations through organic growth and acquisition and believe this subsidiary will contribute significant revenue and value to FOXO in future years. Furthermore as we exit the first half of the year we are excited for the second half of 2025 and look forward to demonstrating continued successes achieved in the second quarter, in our upcoming quarterly report to June 30th, when filed."

Industry Context

This announcement highlights the ongoing efforts to combat the opioid crisis in the United States, particularly in rural areas where access to care can be limited. The continued funding for Myrtle Recovery Centers underscores the critical role of behavioral health facilities in addressing this public health challenge and the importance of local government support. FOXO's diversified portfolio, including a critical access hospital and a biotechnology arm, positions it within the broader healthcare and life sciences sectors, which are subject to evolving regulatory landscapes and significant demand for specialized services.

Comparison to Industry Standards

  • The document does not provide specific comparable companies, projects, or results to assess performance against global benchmarks.

Stakeholder Impact

  • Shareholders: Potential for increased revenue and value from the Myrtle subsidiary, driven by continued funding and operational success.
  • Patients (uninsured from Scott County): Continued access to essential behavioral health services for opioid addiction.
  • Employees (Myrtle clinical team): Continued employment and recognition for providing quality care.
  • Scott County: Ongoing support in addressing the opioid crisis within the community.

Next Steps

  • Myrtle Recovery Centers will begin its second year of receiving Scott County Opioid Abatement Funds on July 1, 2025.
  • FOXO Technologies plans to expand Myrtle into additional locations through organic growth and acquisition.
  • FOXO Technologies will file its quarterly report to June 30th, detailing second-quarter successes.

Key Dates

DateDescription
2025-06-30Date of the 8-K Current Report filing and the press release announcing the funding approval.
2025-07-01Start date for the second year of Scott County Opioid Abatement Funds for Myrtle Recovery Centers, Inc.

Recommendation

buy

Keywords

FOXO Technologies, Myrtle Recovery Centers, Opioid Abatement Funds, Behavioral Health, Substance Abuse Treatment, Scott County, Tennessee Healthcare, Rural Healthcare, SEC Filing, 8-K, Healthcare Services, Biotechnology

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.